TherapeuticsMD (TXMD) Non-cash Items (2021 - 2026)

TherapeuticsMD (TXMD) has reported Non-cash Items for 6 consecutive years, with $615000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-cash Items rose 475.0% year-over-year to $615000.0; the trailing twelve-month figure through Jun 2026 stood at $3.4 million (up 116.05% YoY), and the FY2025 full-year result was $3.1 million, down 10.77% from the prior year.
• Non-cash Items fell to $615000.0 in Q2 2026 per TXMD's latest filing, from $841000.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $32.3 million in Q3 2022 and bottomed at -$18.2 million in Q4 2022.
• Historically, Non-cash Items has averaged $52666.7 across 5 years, with a median of $249500.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Non-cash Items sank 213133.33% in 2023, then surged 1117.53% in 2025.
• Over 5 years, Non-cash Items stood at -$18.2 million in 2022, then soared by 81.23% to -$3.4 million in 2023, then jumped by 97.16% to -$97000.0 in 2024, then soared by 1117.53% to $987000.0 in 2025, then plunged by 37.69% to $615000.0 in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $615000.0, $841000.0, and $987000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.